Inder Verma stepped down as a director of Jubilant Pharma Ltd.
The resignation is effective Aug. 6.
Discover more about S&P Global’s offerings
Jubilant Pharma director resigns
Insight Weekly: Loan delinquencies up; US money supply falls; coal employment grows
Insight Weekly: Loan-to-deposit ratio rises; inventory turnovers ebb; miners add female leaders
Debt Ceiling Debate: IR Teams Should Prepare for Potential Market Downturns
Insight Weekly: Sustainable bonds face hurdles; bad loans among landlords; AI investments up
Inder Verma stepped down as a director of Jubilant Pharma Ltd.
The resignation is effective Aug. 6.